Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Learn more about your ad choices. Visit megaphone.fm/adchoices
COVID isn't the only thing coming this summer
Why it's not worth waiting for Novavax
Why is Indigenous vaccination so patchy?
Don't be scared of bird flu headlines... yet
The NT's worst local COVID-19 day ever
One week until SA throws open the doors
Europe's first winter with Delta is already looking grim
Shouldn't Victoria's numbers be falling by now?
How do I talk to people who don't want to be vaccinated?
Let's dust off the crystal ball!
Keeping schools open through COVID outbreaks
A lot of little kids are getting COVID. Why?
How many people have really died from COVID?
Let's talk about kids and vaccine side effects
Is NSW going to run out of people to vaccinate?
Why so long between scary variants?
Finally we can test ourselves at home!
Boy do you have booster questions! Let's answer some
Should a 3rd dose be required to be FULLY vaccinated?
Will vaccines stop me getting long COVID?
Create your
podcast in
minutes
It is Free
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First from NPR
The Daily